Brief: Sensorion Announces Positive Data Safety Monitoring Board Review Of Phase 2 Trial For SENS-401

Sensorion SA

23/12/2019 16:48

Dec 23 (Reuters) - SENSORION SA  ALSEN.PA :
    * SENSORION ANNOUNCES POSITIVE DATA SAFETY MONITORING BOARD
REVIEW
OF PHASE 2 TRIAL FOR SENS-401 IN SUDDEN SENSORINEURAL HEARING
LOSS
    * AROUND 260 PATIENTS ARE EXPECTED TO BE ENROLLED IN TRIAL
AND
RESULTS ARE EXPECTED AT END OF H1 2020
    * DSMB REVIEW IS PART OF REGULAR MONITORING OF MULTI-CENTER
AND
RANDOMIZED PHASE 2 CLINICAL TRIALS

Source text for Eikon:  ID:nBw3vmFsra 
Further company coverage:  ALSEN.PA 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com;))